MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
Forums
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

WORLDiscoveries

WORLDiscoveries
WORLDiscoveries™ is the business development arm of London’s extensive research network and the bridge between local invention and global industry.

The company in detail

Profile

WORLDiscoveries™ is the business development arm of London’s extensive research network and the bridge between local invention and global industry. 

Born out of a partnership between The University of Western Ontario, Robarts Research Institute and Lawson Health Research Institute, WORLDiscoveries draws upon a mix of industry connections, sector-specific market knowledge and business development expertise, to help researchers and local inventors commercialize their discoveries through licensing and new company spin-offs.

In delivering this value proposition, WORLDiscoveries will be a material contributor to the sustained financial health and vitality of London’s Research Row and the community at large.

London’s Research Row is a new concept used to describe a geographical band that is home to a large number of London’s Research-based institutions.  The Row, which employs nearly 2,000 researchers and conducts over $330 million in research annually,  runs in a notional straight line from Western’s Research Park south to the London Heath Sciences Centre Victoria Hospital Campus and includes all of London’s Hospitals, Lawson Health Research Institute, NRC, Robarts Research Institute, CSTAR, Children’s Health Research Institute and the University of Western Ontario. 

More importantly, WORLDiscoveries seeks to;

  1. Remain one of the top five business development offices in Canada.
  2. Substantially increase the number of Spin-off companies in the region.
  3. Establish WORLDiscoveries and Research Row as a preeminent commercialization centre in North America by 2012.

WORLDiscoveries represents a new and exciting means of bringing local knowledge and invention to the global market and the global market to our local economy.

Partnering strategy/interests

WORLDiscoveries is excited to work with your company to bring London’s innovative technologies to the world. 

Browse our pharmalicensing listing to see if any of our current technologies meet your company’s needs or contact any member of our team to find out if your unique technology need can be met by a WORLDiscoveries researcher.

If a WORLDiscoveries product attracts your company’s interest, our team will work hard to create a partnership that generates a fair return to you, our industry partner, as well as to our research and institutional partners and the community at large.

Out-licensing

A renowned cardiologist and Robarts' Scientist has identified a strong correlation between a polymorphism of a relatively new apolipoprotein gene and severity of hypertiglyceridemia manifestation. More
A Robarts' Scientist has generated a target-based primary in vitro cell-based screen for evaluating compounds or peptides affecting scar matrix deposition and remodeling during wound repair. More
An innovative, real-time test of oocyte quality, applicable to assisted conception treatments, that does no harm to the oocyte itself. More
A diagnostic and therapeutic secreted target protein that is upregulated in a subset of human patients with Osteoarthritis. It is a strong regulatory candidate for the transformation of maintenance chondrocytes into digestive aggravators of OA. More
This invention relates to methods for manipulating the immune system using small interfering RNA (siRNA). Potential applications include the development of organ storage/reperfusion solutions and treatments for a broad range of disease indications. More
This invention concerns identification of the first serum tumour marker for monitoring the initiation and progression of prostate cancer (CaP) in animal models. More
Our invention relates to a novel anti-cancer therapy involving the silencing of tumour-derived immunosuppressive genes using siRNA. More
Our passive immunity patent portfolio concerns the local or topical administration of monoclonal or polyclonal antibody compositions in the prevention and treatment of infectious disease. More
This invention concerns a new approach to the treatment of rheumatoid arthritis (RA) by "tolerogenic vaccination" with small interfering RNA (siRNA) technology. More
This invention relates to an animal model showing several behavioral and neuropathological features of schizophrenia. More
This invention relates to a new siRNA-containing organ storage and reperfusion solution for use in transplantation. More
New methods for treating, minimizing and/or preventing inflammatory injury mediated by the activity of interleukin 2 (IL-2) on non-T cells, such as epithelial cells, expressing IL-2 receptors (IL-2R) More
This invention concerns the oral and intravenous administration of sodium 2-mercaptoethylsulfonate (MESNA) in the treatment of hyperhomocysteinemia. More
This invention concerns the discovery of novel autoantigenic peptides useful for the diagnosis and treatment of rheumatoid arthritis. More
This technology concerns separate inventions to specific compositions of hyaluronan (HA) fragments and/or agents useful for wound healing or the treatment of cancer. More
This invention concerns the development of a new biomarker panel for the detection and diagnosis of Type 1 diabetes. More
Western inventors have identified a group of 12 differentially expressed proteins in Preeclampsia (PE) patients using a state-of-art proteomics based approach. More
The present invention relates to methods comprising of specialized mononuclear cells from bone marrow that can rescue hyperglycemia and augment pancreatic repair. More
A novel combination of growth factors that may serve as a basis for promoting blood vessel formation in vitro as well as promoting of the investment of those vessels with smooth muscle cells. More
A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More
A novel cyclized histatin-based peptide DB2-121 that is a potent new antifungal agent active against the clinically important Candida albicans and a number of other organisms. More
A non-invasive development of a test for the diagnosis and monitoring of endometriosis. More
The present invention relates to osteoarthritis (OA) and methods of OA diagnosis and treatment via the findings of a genome-wide analysis of dysregulated genes in OA. More
An inexpensive and easy-to-use method for early HIV detection More
A ghrelin-based probe/therapeutic More
A flexible, portable, versatile handheld platform that will be useful for a variety of Audiology and Speech Language Pathology applications. More
A new universal RSA calibration system that eliminates the need for joint-specific calibration boxes and analysis. 40% to 70% more accurate than existing technologies. More
A new excitation pulse sequence for the acquisition of Magnetic Resonance Imaging (MRI) data of particular usefulness in Magnetic Resonance Angiography (MRA). More
This invention relates to a computer-controlled physiological flow simulator for use in the study of vascular hemodynamics and the calibration of clinical imaging systems used to measure blood flow More
This invention concerns a position and orientation sensor designed for use with existing ultrasound instrumentation to permit the real-time measurement of blood volume flow rate within a vessel. More
These inventions describe novel ultrasound systems and methods of obtaining high quality three-dimensional (3-D) images of a target volume. More
This invention concerns the design of an ultrasound transducer mounting assembly incorporating a novel tracking device. More
This invention describes a three-dimensional (3-D) ultrasound system and process of performing percutaneous tissue biopsy for the diagnosis of breast cancer. More
An ultrasound image-guided system and method for obtaining an accurate knowledge of the 3-D geometry of the prostate; allowing for exact positioning of needles for the delivery of seeds to cancerous cells More
This invention concerns a system and method of obtaining four-dimensional (4-D) ultrasound images of moving tissue such as the human heart or lungs, where time is the fourth dimension. More
This invention relates to a novel radiotracer that has proven effective for use in SLN scintigraphy during the surgical detection and treatment of breast cancer More
A novel angioradiographic apparatus to quantitatively determine the velocity and flow rate of blood throughout the cardiac cycle. More
The current invention concerns a novel apparatus and method for the preparation of frozen tissue specimens for thin sectioning outside of the cryostat. More
A method for the early prediction of foetal health compromise due to foetal asphyxia with progressive acidemia More
Researchers at the University of Western Ontario have developed a Pulmonary Drug Delivery Technology Suite comprised of two innovative inventions for the precision measurement and dispensing of micro fine, dry powders. More
A micro-photonic pressure sensor based on PC waveguides is fabricated using planar SOI technology. More
A highly metastatic murine breast cancer cell line that provides an excellent mouse model for fundamental as well as therapeutic studies of human breast cancer metastasis. More
A novel mutagenesis system that enables the creation of unmarked and targeted deletions in Burkholderia strains. More
A powerful technology for the simultaneous monitoring of protein kinase activities in cell and tissue extracts using a multiplexed electrochemical assay More
A non-pathogenic strain of Burkholderia cepacia provides an opportunity to develop a live vaccine to prevent Bcc infection in CF and critically ill patients, which would dramatically improve the quality of life and life expectancy of these patients. More
A non-transgenic, adult onset rodent model for Alzheimer's disease and stroke. More
A novel disposable contact lens biosensor for the continuous, non-invasive monitoring of physiological glucose for diabetic patients More
Suite of proprietary collagen-binding peptides derived from bone sialoprotein (BSP) that are effective in promoting bone repair and regeneration. More
A novel drug target and peptide(s) designed to inhibit protein synthesis by specifically preventing formation of the 43S preinitiation complex More
A novel methodology of regulating and inducing stem cell differentiation by altering the expression of a key protein that is naturally existing and participating in embryo development More
A suite of highly specific, proprietary bacterial drug targets in staphylococcus aureus, that can be used individually or as a group to develop small molecule or peptide drug leads with powerful anti-infectives properties. More
A number of select phospho-peptides that are derived from the crystal-inhibiting protein osteopontin and that have a distinct set of structural criteria. More
This algorithm is used with existing technology to rapidly optimize cancer radiation therapy treatment plans. Also, it has the potential to revolutionize radiation therapy by serving as the platform for adaptive radiation therapy. More
Identification and use of RAR antagonists to induce bone and cartilage formation More
Western researchers have developed a novel technique, Swallowing Air-Pulse Therapy (SWAPT) and an associated device Swallowing Air-Pulse Therapy System (SWAPTS). More
A Robarts' Scientist has identified a target molecule that can serve as a switch between scar establishment and regenerative matrix deposition by astroctye cells. More
A novel combination of growth factors that may serve as a basis for promoting blood vessel formation, and stabilizing those vessels whose stability may be compromised More

Press Releases

(5th Nov 2007) Scientists at Robarts Research Institute have developed a simplified and more effective method of treating high blood pressure. More
(9th Oct 2007) Scientists at Robarts Research Institute and The University of Western Ontario find marker for addressing infection in patients undergoing peritoneal dialysis. More
(10th Dec 2007) Elderly patients who undergo hip and knee replacement surgery experience less pain and require 80 per cent less narcotics as a result of a newly developed drug combination administered before, during, and after surgery More
(29th Jan 2008) Improved techniques to better diagnose diseases such as brain cancer, epilepsy, stroke, and Alzheimer's disease is the goal of new research in London funded by the McGuinty government. More
(7th Feb 2008) Western's Experimental Eye Research Facility brings professionals from different backgrounds together to study the eye. More
(14th Feb 2008) Assisted by advanced technology, some of the sharpest minds at Western work to solve the mysteries of the brain. More
(22nd Feb 2008) An international Robarts research study opens the door to a safer and more effective treatment option for Crohn's disease More
(26th Mar 2008) Public Lecture with Robarts geneticist Dr. Robert Hegele, March 27, 2008 More
(27th Mar 2008) The newly funded lab, led by Anatomy & Cell Biology professor Lynne-Marie Postovit at the Schulich School of Medicine & Dentistry, will look at the types of microenvironments that regulate both normal and cancer cell plasticity and function. More
(2nd Apr 2008) Robarts Research Institute, (at The University of Western Ontario) London, for Dr. Aaron Fenster's 3-D ultrasound-guided intra-operative and dynamic minimally invasive brachytherapy and biopsy platform More
More press releases

Contact details

Heather Dimson
Business Development Manager, E-Comm
WORLDiscoveries™ at MaRS Toronto

Contact directly

Full contact list

Head office

WORLDiscoveries
Gordon Mogenson Building, Suite 105
100 Collip Circle
The University of Western Ontario Research Park
London
N6G 4X8
Ontario

Full offices list

Company figures

Formed: 1996
Annual Turnover: 4,447,953 (2009)
Number of employees: 12

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
The countdown has started...
Need competitive intelligence information
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us